Literature DB >> 26218616

Synthetic biology approaches to engineer T cells.

Chia-Yung Wu1, Levi J Rupp1, Kole T Roybal1, Wendell A Lim2.   

Abstract

There is rapidly growing interest in learning how to engineer immune cells, such as T lymphocytes, because of the potential of these engineered cells to be used for therapeutic applications such as the recognition and killing of cancer cells. At the same time, our knowhow and capability to logically engineer cellular behavior is growing rapidly with the development of synthetic biology. Here we describe how synthetic biology approaches are being used to rationally alter the behavior of T cells to optimize them for therapeutic functions. We also describe future developments that will be important in order to construct safe and precise T cell therapeutics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26218616      PMCID: PMC4553068          DOI: 10.1016/j.coi.2015.06.015

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  48 in total

Review 1.  Cancer therapy with bispecific antibodies: Clinical experience.

Authors:  Archana Thakur; Lawrence G Lum
Journal:  Curr Opin Mol Ther       Date:  2010-06

Review 2.  CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer.

Authors:  Markus Chmielewski; Hinrich Abken
Journal:  Cancer Immunol Immunother       Date:  2012-01-25       Impact factor: 6.968

3.  Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems.

Authors:  Yvonne Y Chen; Michael C Jensen; Christina D Smolke
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

4.  A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.

Authors:  Xiuli Wang; Wen-Chung Chang; ChingLam W Wong; David Colcher; Mark Sherman; Julie R Ostberg; Stephen J Forman; Stanley R Riddell; Michael C Jensen
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

Review 5.  T-cell engineering for cancer immunotherapy.

Authors:  Michel Sadelain
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

Review 6.  Design principles of regulatory networks: searching for the molecular algorithms of the cell.

Authors:  Wendell A Lim; Connie M Lee; Chao Tang
Journal:  Mol Cell       Date:  2013-01-24       Impact factor: 17.970

7.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

8.  Reversal of tumor immune inhibition using a chimeric cytokine receptor.

Authors:  Ann M Leen; Sujita Sukumaran; Norihiro Watanabe; Somala Mohammed; Jacqueline Keirnan; Ryu Yanagisawa; Usanarat Anurathapan; David Rendon; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Juan F Vera
Journal:  Mol Ther       Date:  2014-03-20       Impact factor: 11.454

9.  In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells.

Authors:  Luca Biasco; Serena Scala; Luca Basso Ricci; Francesca Dionisio; Cristina Baricordi; Andrea Calabria; Stefania Giannelli; Nicoletta Cieri; Federica Barzaghi; Roberta Pajno; Hamoud Al-Mousa; Alessia Scarselli; Caterina Cancrini; Claudio Bordignon; Maria Grazia Roncarolo; Eugenio Montini; Chiara Bonini; Alessandro Aiuti
Journal:  Sci Transl Med       Date:  2015-02-04       Impact factor: 17.956

10.  Sending mixed messages for cell population control.

Authors:  Hyun Youk; Wendell A Lim
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  12 in total

1.  An immunoproteomic approach to characterize the CAR interactome and signalosome.

Authors:  Maria C Ramello; Ismahène Benzaïd; Brent M Kuenzi; Maritza Lienlaf-Moreno; Wendy M Kandell; Daniel N Santiago; Mibel Pabón-Saldaña; Lancia Darville; Bin Fang; Uwe Rix; Sean Yoder; Anders Berglund; John M Koomen; Eric B Haura; Daniel Abate-Daga
Journal:  Sci Signal       Date:  2019-02-12       Impact factor: 8.192

2.  In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

Authors:  Tyrel T Smith; Sirkka B Stephan; Howell F Moffett; Laura E McKnight; Weihang Ji; Diana Reiman; Emmy Bonagofski; Martin E Wohlfahrt; Smitha P S Pillai; Matthias T Stephan
Journal:  Nat Nanotechnol       Date:  2017-04-17       Impact factor: 39.213

3.  Multiscale engineering of immune cells and lymphoid organs.

Authors:  Sungwoong Kim; Shivem B Shah; Pamela L Graney; Ankur Singh
Journal:  Nat Rev Mater       Date:  2019-04-03       Impact factor: 66.308

4.  T cell circuits that sense antigen density with an ultrasensitive threshold.

Authors:  Katelyn A Cabral; Olivia A Creasey; Rogelio A Hernandez-Lopez; Wei Yu; Maria Del Pilar Lopez Pazmino; Yurie Tonai; Arsenia De Guzman; Anna Mäkelä; Kalle Saksela; Zev J Gartner; Wendell A Lim
Journal:  Science       Date:  2021-02-25       Impact factor: 47.728

5.  Rapid generation of hypomorphic mutations.

Authors:  Laura L Arthur; Joyce J Chung; Preetam Jankirama; Kathryn M Keefer; Igor Kolotilin; Slavica Pavlovic-Djuranovic; Douglas L Chalker; Vojislava Grbic; Rachel Green; Rima Menassa; Heather L True; James B Skeath; Sergej Djuranovic
Journal:  Nat Commun       Date:  2017-01-20       Impact factor: 14.919

6.  CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.

Authors:  Levi J Rupp; Kathrin Schumann; Kole T Roybal; Rachel E Gate; Chun J Ye; Wendell A Lim; Alexander Marson
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

7.  Multi-compartment encapsulation of communicating droplets and droplet networks in hydrogel as a model for artificial cells.

Authors:  Mariam Bayoumi; Hagan Bayley; Giovanni Maglia; K Tanuj Sapra
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

8.  Self-adjusting synthetic gene circuit for correcting insulin resistance.

Authors:  Haifeng Ye; Mingqi Xie; Shuai Xue; Ghislaine Charpin-El Hamri; Jianli Yin; Henryk Zulewski; Martin Fussenegger
Journal:  Nat Biomed Eng       Date:  2016-12-19       Impact factor: 25.671

9.  Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells.

Authors:  Mara Kornete; Romina Marone; Lukas T Jeker
Journal:  J Immunol       Date:  2018-02-14       Impact factor: 5.422

Review 10.  Synthetic immunology: T-cell engineering and adoptive immunotherapy.

Authors:  Wen Si; Cheng Li; Ping Wei
Journal:  Synth Syst Biotechnol       Date:  2018-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.